Clinical trial registry record

Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 28, 2021.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02261961
Last registry update
September 28, 2021
Status
Completed
Phase
Phase not reported
Sponsor
VA Office of Research and Development
Enrollment
59
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · BASIC SCIENCE · TRIPLE
Evidence population
Human clinical study registration
Participants
59
Population
ALL · 60 Years to 80 Years
Duration
2014-07-23 to 2019-09-30
Intervention
TDAP; Acute Resistance Exercise; Resistance Exercise Training; Post-training Follow-up; Nutritional Supplement (Muscle Armor); Placebo (Kool-Aid)
Comparator
Placebo
Outcomes measured
Change in Plasma Concentration of Antibodies to Pertussis Antigen (1 Week Post-vaccine) — change from baseline at 1 wee…; Change in Plasma Concentration of Antibodies to Pertussis Antigen (2 Weeks Post-vaccine) — change from baseline at 2 we…; Change in Plasma Concentration of C-Reactive Protein — change from baseline at 2 weeks of treatment; Change in the Number of Muscle Macrophages Per Myofiber (Pre- to Post-acute Exercise) — change from baseline at 2 weeks…; Change in Muscle Strength After Exercise Training for 12 Weeks — change from baseline at completion of exercise trainin…; Change in Plasma Concentration of Antibodies to Tetanus Antigen (1 Week Post-vaccine) — change from baseline at 1 week…; Change in Plasma Concentration of Antibodies to Tetanus Antigen (2 Weeks Post-vaccine) — change from baseline at 2 week…; Change in Plasma Concentration of Antibodies to Diptheria Antigen (1 Week Post-vaccine) — change from baseline at 1 wee…; Change in Plasma Concentration of Antibodies to Diptheria Antigen (2 Weeks Post-vaccine) — change from baseline at 2 we…; Number of Muscle Macrophages Per Myofiber (Resting) — change from baseline at 2 weeks of treatment; Change in Muscle Size After Exercise Training for 12 Weeks — change from baseline at completion of exercise training ph…; Change in Muscle Strength at Week 16 of the Post-Training Period — difference between baseline and time point one of de…; Change in Balance After Exercise Training for 12 Weeks — change from baseline at completion of exercise training (12 we…; Change in Balance During the Post-Training Period at 26 Weeks of the Post-training Period — difference between time of…; Change in Balance at Week 16 of the Post-Training Period — difference between time of training completion and time poin…; Change in Walking Ability After Exercise Training for 12 Weeks — change from baseline at completion of exercise trainin…; Change in Walking Ability at Week 16 of the Post-Training Period — difference between end of training and time point on…; Change in Walking Ability at Week 26 of the Post-Training Period — difference between end of training and time point tw…; Change in Gait Speed After Exercise Training for 12 Weeks — change from baseline at completion of exercise training (12…; Change in Gait Speed at Week 16 of the Post-Training Period — difference between after training and time point one of d…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.